Neuralink Corp., the brain implant startup led by billionaire Elon Musk, is recruiting patients for a clinical trial, a long-awaited step that brings the science fiction-esque technology closer to human reality.
In a blog post, the company said it was recruiting patients with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) for the trial. Neuralink plans to evaluate the safety and functionality of its tool allowing people to manipulate external devices with their minds.
The initial goal “is to grant people the ability to control a computer cursor or keyboard using their thoughts alone,” the company said in the post.
Read the full story on Bloomberg here.